Skip to content

Outcomes of Treatment Using the ERMI Shoulder Flexionater ®

Outcomes of Treatment Using the ERMI Shoulder Flexionater®

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05384093
Enrollment
210
Registered
2022-05-20
Start date
2019-06-25
Completion date
2026-10-25
Last updated
2026-09-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adhesive Capsulitis of Shoulder

Brief summary

Study 1 - Adhesive Capsulitis Study - 110 patients The purpose of this study is to compare treatment of patients with symptoms of adhesive capsulitis, primary and secondary, between three groups: I) Physical Therapy alone; II) ERMI Shoulder Flexionater® alone; III) PT + Device. Study 2 - Postoperative Shoulder Stiffness Study - 90 patients The purpose of this study is to compare treatment of patients with post-operative stiffness indicative of secondary adhesive capsulitis between three groups: I) Physical Therapy alone; II) ERMI Shoulder Flexionater® alone; III) PT + Device. Study 3 - Stiffness after MUA Study - enroll all eligible patients (goal of at least 15) The purpose of this study is to compare treatment of patients who have undergone manipulation under anesthesia or lysis of adhesions between three groups: I) Physical Therapy alone; II) ERMI Shoulder Flexionater® alone; III) PT + Device.

Detailed description

Study 1 - Adhesive Capsulitis Study (AC) Objective: The purpose of this study is to compare treatment efficacy of patients with symptoms of primary and secondary adhesive capsulitis between three groups: 1) Patients treated with Physical Therapy alone; 2) Patients treated with the ERMI Shoulder Flexionater® alone; 3) Patients treated with PT + Device in the treatment. 1. Prospective randomized control trial 2. Sample size - 110 patients 3. Study Groups: 1. Group I - Physical Therapy Only 2. Group II - Flexionater® only 3. Group III - Flexionater® and Physical Therapy 4. Length of study - 2-year follow-up from last enrolled patient Study 2 - Postoperative Shoulder Stiffness Study (POS) Objective: The purpose of this study is to compare treatment efficacy of patients with post-operative stiffness indicative of secondary adhesive capsulitis between three groups: I) Patients treated with Physical Therapy alone; II) Patients treated with the ERMI Shoulder Flexionater® alone; III) Patients treated with PT + Device in the treatment. 1. Prospective randomized control trial 2. Sample size - 90 enrolled patients 3. Study Groups: 1. Group I - Physical Therapy only 2. Group II - Flexionater® only 3. Group III - Flexionater® and Physical Therapy 4. Length of study - 2-year follow-up from last enrolled patient Study 3 - Secondary Surgery Study (SAM) Objective: The purpose of this study is to compare recovery of patients who have undergone a manipulation under anesthesia or a lysis of adhesions between three groups: 1) Patients treated with Physical Therapy alone; 2) Patients treated with the ERMI Shoulder Flexionater® alone; 3) Patients treated with PT + Device in the treatment. 1. Prospective randomized control trial 2. Sample size - 10 enrolled patients 3. Study Groups: 1. Group I Physical Therapy Only 2. Group II - - Flexionater® only 3. Group III - Flexionater® and Physical Therapy 4. Length of study - 2-year follow-up from last enrolled patient

Interventions

DEVICEHigh Intensity Stretch Device

High Intensity Stretch and Physical Therapy are used either together or alone to treat study arm.

Sponsors

Foundation for Orthopaedic Research and Education
Lead SponsorOTHER
Ermi LLC
CollaboratorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

For Study Group 1- Adhesive Capsulitis (AC) Inclusion Criteria: * Exhibits symptoms of adhesive capsulitis i. Shoulder pain with limited motion for more than one month ii. AND ≤ 30 degrees external rotation with arm at side iii. AND ≤ 130 degrees forward flexion d. Cortisone shot for all patients

Exclusion criteria

* a. No prior shoulder surgery b. Infection c. Rheumatoid arthritis d. Any structural or systemic disorder that could result in pain or ROM limitation i. Such as inflammatory joint disease, osteoarthritis evidenced on radiographs ii. full thickness rotator cuff tear as shown by ultrasound imaging iii. history of major trauma or surgery involving the shoulder For Study Group 2 - Postoperative Shoulder Stiffness Study (POS) Inclusion Criteria: c. Is not recovering normally based on objective criteria set for screening process i. Step 1 - Follow patients -all post-op patients with indicated procedures (see # 7 for list.) ii. Step 2 - Screen Patients -does patient meets inclusion criteria at 6 weeks or 3 months of follow-up? 1. \< 15 degrees external rotation with arm at side at 6 weeks post-op 2. OR \< 90 degrees forward flexion at 3 months post-op iii. Step 3 - Enroll patients that meet inclusion criteria and assign group

Design outcomes

Primary

MeasureTime frameDescription
Shoulder Range of Motion Improvement3 monthsMeasuring Shoulder External Rotation and Forward Flexion using a goniometer according to standard practice
Shoulder Range of Motion6 monthsMeasuring Shoulder External Rotation and Forward Flexion using a goniometer according to standard practice
VAS (Visual Analog Scale) Pain Score3 monthsVisual Analog Scale Pain Score 0 (no pain) - 10 (pain as bad as it can be)
VAS Pain Score6 weeksVisual Analog Scale Pain Score: 0 (no pain) - 10 (pain as bad as it can be)
ASES ScorebaselineAmerican Shoulder and Elbow Society Score (10 activities of daily living are calculated)

Secondary

MeasureTime frameDescription
SSTBaselineSimple Shoulder Test
Device Compliance Questionnaire (if applicable)6 weekscompliance with Device usage

Countries

United States

Contacts

STUDY_DIRECTORPeter Simon, PhD

Foundation for Orthopaedic Research and Education

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 10, 2026